NCT00691665

Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial

A Double-masked, Randomized, Parallel Group, Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 130 (actual)
• Sponsor: Alcon Research · Industry
• Sex: All
• Age: 12 Years
• Healthy volunteers: Accepted

Summary

Comparison of two nasal sprays for the treatment of seasonal allergic rhinitis

Conditions

• Seasonal Allergic Rhinitis

Interventions

Type	Name	Description
DRUG	Olopatadine HCL Nasal Spray, 0.6%	Olopatadine HCL Nasal Spray, 0.6% 2 sprays per nostril twice daily
DRUG	Fluticasone Propionate Nasal Spray, 50 mcg	Fluticasone Propionate Nasal Spray, 50 mcg 2 sprays per nostril once daily

Timeline

• Start date: 2008-05-01
• Primary completion: 2009-01-01
• First posted: 2008-06-05
• Last updated: 2010-03-30
• Results posted: 2010-03-10

Locations

1 site across 1 country: United States